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Abstract
Background: Abdominal bloating is a common symptom in patients with irritable bowel syndrome with
constipation (IBS-C). However, it is not included among the required items in the Rome III diagnostic criteria
for IBS. Little is known about an impact of abdominal bloating seen in patients with IBS-C. Using a large
population-based sample, the aim of the present study was to investigate what is the most bothersome
symptom in subjects with IBS-C.
Methods: An Internet survey of 30,000 adults drawn from the general public throughout Japan was
conducted to identify subtypes of IBS using the Rome III diagnostic questionnaire. Consecutively, the screened
subjects with IBS-C and the same number of age- and sex-matched non-IBS subjects who were randomly
selected as controls were asked to answer a questionnaire on the degree of anxiety they experienced in their
daily lives, thoughts about bowel habit, and their dominant gastrointestinal symptoms together with
exacerbation factors (for IBS-C only).
Results: The screening survey showed that the prevalence of overall IBS was 16.5 % (female 17.4 %, male 15.
5 %) and that 2.8 % met the criteria for IBS-C, 4.5 % for IBS with diarrhea (IBS-D) and 8.2 % for mixed IBS
(IBS-M). Seven hundred and fifty-nine of 835 (90.9 %) subjects with IBS-C and 746 of 830 (89.9 %) control
subjects completed the consecutive questionnaire. IBS-C subjects felt a higher degree of anxiety in their daily
lives (p < 0.01) and considered bowel habit to be an indicator of health (p < 0.01) to a greater extent than
control subjects. In IBS-C, the degree of anxiety was significantly associated with abdominal discomfort
(p < 0.01), pain (p < 0.01) and bloating (p = 0.02), but not with the frequency of bowel habit (p > 0.1).
Abdominal bloating was the most bothersome symptom (27.5 %), which was more likely to occur after a
meal (52.2 %), at work/school (29.2 %) and during times of stress (26.8 %). Only 4.5 % of IBS-C subjects
reported abdominal pain as the ‘most bothersome’ symptom.
Conclusions: A large population-based Internet survey suggests that abdominal bloating has a great impact
on the daily lives of subjects diagnosed with IBS-C. Not only bowel movement/abdominal pain but also
abdominal bloating should be evaluated in patients with IBS-C.
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Background
Irritable bowel syndrome (IBS) is a common functional
gastrointestinal (GI) disorder that affects between 10
and 20 % of the population worldwide [1]. Based on the
Rome III diagnostic criteria for functional GI disorders,
IBS is defined as recurrent abdominal pain or discomfort
(at least 3 days per month in the last 3 months) associ-
ated with at least two of the following: improvement
with defecation, onset associated with a change in stool
frequency, and/or onset associated with change in stool
form [2]. The diagnosis of IBS is subtyped by the pre-
dominant stool pattern: constipation (IBS-C), diarrhea
(IBS-D), mixed (IBS-M), or unspecified (IBS-U) [2].
Approximately two-thirds of subjects with IBS relate
their symptoms to their intake of food [3, 4]. Most of
IBS patients modify their diet, and these modifications
sometimes result in an inadequate diet [3] which may be
associated with bowel symptoms. Patients with IBS also
feel more stress compared to healthy subjects in their
daily life [5, 6]. IBS symptoms often exaggerate when
patients feel stress and/or anxiety [7]. Moreover, it has
been reported that menstruation was associated with a
worsening of abdominal pain and bloating and with
more increase in rectal pain sensitivity compared with
most other phases of the menstrual cycle in patients
with IBS [8].
Abdominal bloating is commonly reported by patients
with IBS [9]. However, it is not included among the
required items in the Rome III diagnostic criteria [2].
Patients with IBS-C show more abdominal bloating and/
or distention than those with IBS-D [10]. Constipation is
often associated with delayed gastrointestinal transit
[11]. The severity of abdominal bloating correlated
strongly with the degree of abdominal distention only in
IBS-C [12], suggesting that the pathophysiology is likely
to be different between subtypes of bowel habit.
In general population, we have found that even
non-consulters with IBS showed more impaired qual-
ity of life (QOL) compared to non-IBS subjects as
well as patients with IBS [6, 13]. It has been reported
that IBS symptom severity was associated with lower
QOL [14, 15]. However, little is known about an im-
pact of IBS symptoms including abdominal bloating
seen in patients with IBS-C. Using a large population-
based sample, the aim of the present study was to
investigate what is the most bothersome symptom in
subjects with IBS-C.
Methods
As a preliminary survey, an Internet survey of 30,000
adults drawn from the general public throughout Japan
(that is, from 47 prefectures in Japan) was conducted to
identify subtypes of IBS. Participants were required to
meet the following criteria to be eligible for the survey:
(1) no conflicts of interest with advertising, marketing
research, health care, or pharmaceutical/chemical compan-
ies; (2) 20-79 years of age; and (3) subjects who understand
Japanese and were living in Japan. They were randomly
selected using an online survey system (Automatic Internet
Research System: AIRs, Macromill, Inc., Japan). Same
numbers of males and females from the different five
aged groups (20s, 30s, 40s, 50s and 60–79 years; 3000
subjects each) registered with the Macromill monitor
panel (Macromill, Inc., Japan) were recruited during
October 28–31, 2013 (Table 1).
Table 1 Demographics of study subjects (Preliminary study)
Participants
(n = 30,000), n (%)
Gender and age range (years)
20-29 in females 3000 (10)
20-29 in males 3000 (10)
30-39 in females 3000 (10)
30-39 in males 3000 (10)
40-49 in females 3000 (10)
40-49 in males 3000 (10)
50-59 in females 3000 (10)
50-59 in males 3000 (10)
60-79 in females 3000 (10)
60-79 in males 3000 (10)
Marital status
Married 17,391 (58)
Not married 12,609 (42)
Annual household income (yen)
< 2 million 2557 (8.5)
2-4 million 6818 (22.7)
4-6 million 6564 (21.9)
6-8 million 3940 (13.1)
8-10 million 2321 (7.7)
10-12 million 1089 (3.6)
12-15 million 691 (2.3)
15-20 million 300 (1.0)
≧20 million 146 (0.5)
unknown 2795 (9.3)
not answered 2779 (9.3)
Diagnosis of IBS
non-IBS 25,058 (83.5)
IBS (overall) 4942 (16.5)
IBS with constipation (IBS-C) 835 (2.8)
IBS with diarrhea (IBS-D) 1359 (4.5)
Mixed IBS (IBS-M) 2452 (8.2)
Unspecified IBS (IBS-U) 296 (1.0)
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The IBS module on the Japanese version of the Rome
III diagnostic questionnaire of which the validity and
reliability have already been confirmed [16, 17] was used
to identify IBS and subtypes of bowel habit (Additional
file 1: Figure S1). IBS-C was defined when a patient
reported hard or lumpy stools ≥25 % of the time,
and loose or watery stools <25 % of the time, IBS-D
was defined when a patient reported loose or watery
stools ≥25 % of the time, and hard or lumpy stools <25 %
of the time, IBS-M was defined when the patient reported
loose or watery stools ≥25 % of the time, and hard or
lumpy stools ≥25 % of the time, and IBS-U was defined
when the patient could not be subtyped according to these
criteria, but met all other diagnostic criteria for IBS [2].
Additionally, frequency of abdominal bloating/distention
in the last 3 months was also asked. The online system
guided participants to complete the questionnaire without
remaining missing item answers.
Consequently, of the 30,000 participants, the screened
subjects diagnosed as IBS-C and the same number of
age- and sex-matched non-IBS subjects who were ran-
domly selected as controls were invited to a main survey
during November 1–4, 2013.
In the main survey, IBS-C subjects and controls were
asked to answer a questionnaire which consists of 7
items on the degree of anxiety they experienced in their
daily lives, number of bowel movement in a week
and thoughts about bowel habit, and 6 items on their
dominant GI symptoms (from the first to the third
place) together with exacerbation factors such as situ-
ations and time periods in their daily lives (for IBS-C
only, Additional file 2: Figure S2).
We conducted an anonymous Internet survey but
regarded the online response as obtained informed con-
sent for the present study. The disclosure of this study
was approved by the Ethics Committee of Tohoku Univer-
sity School of Medicine (approval number: 2015-1-405).
The Mann–Whitney U-test or χ2 test was used for
comparisons between two groups. The Kendall’s τ-b was
used to evaluate associations between the symptoms and
exacerbation factors among IBS-C. The level of statis-
tical significance was set at a P-value of less than 0.05.
Results
The preliminary survey
The demographics of 30,000 participants were shown in
Table 1. Mean age with standard deviation (SD) of the
participants was 45 ± 14 years. The screening survey
showed that the prevalence of overall IBS was 16.5 %
(female 17.4 %, male 15.5 %) and that 2.8 % met the
criteria for IBS-C, 4.5 % for IBS-D, 8.2 % for IBS-M, and
1.0 % for IBS-U. Subjects with IBS (n = 4942) were more
likely to be female (53.0 vs. 49.4 %, p < 0.01) and were
younger (42 ± 14 vs. 45 ± 15 years, p < 0.01) compared to
non-IBS subjects (n = 25,058). IBS-C subjects alone
(n = 835) were much more likely to be female (72.2 vs.
49.4 %, p < 0.01) but were older (47 ± 14 vs. 45 ± 15 years,
p < 0.01) compared to non-IBS subjects. There was no sig-
nificant difference in annual household income between
IBS and non-IBS subjects. Subjects with IBS (overall,
70.0 %; IBS-C, 84.2 %; IBS-D, 53.3 %; IBS-M, 76.6 %; IBS-
U, 51.7 %) were more likely to report abdominal bloating
for at least two to three days a month compared to non-
IBS subjects (19.5 %, p < 0.01, respectively).
The main survey
Seven hundred and fifty-nine of 835 (90.9 %, 541 females)
subjects with IBS-C and 746 of 830 (89.9 %, 537 females)
age- and sex-matched subjects with non-IBS (con-
trols) completed the consecutive questionnaire. IBS-C
subjects felt a higher degree of anxiety in their daily
lives (p < 0.01) and considered bowel habit to be an
indicator of health (p < 0.01) to a greater extent than
control subjects (Table 2).
The most common symptom associated with constipa-
tion in subjects with IBS-C was abdominal bloating
(80.1 %) and was followed by excessive gas (71.3 %) and
abdominal discomfort (64.3 %), whereas 29.1 % of IBS-C
subjects reported abdominal pain during constipation
(Table 3). The degree of anxiety was significantly associated
with abdominal discomfort (Kendall’s τ = 0.09, p < 0.01),
pain (τ = 0.11, p < 0.01), and bloating (τ = 0.08, p = 0.02), but
not with the frequency of bowel habit (τ = -0.04, p > 0.1,
Table 3).
As shown in Fig. 1 and Table 4, the most bothersome
symptom in subjects with IBS-C was abdominal bloating
(27.5 %, 163 females and 46 males), which was more
likely to occur after a meal (52.2 %), at work/school
(29.2 %), during times of stress (26.8 %) and during
menstruation (11.7 %, females only). Only 4.5 % of IBS-
C subjects (25 females and 9 males) reported abdominal
pain as the most bothersome symptom, which was more
likely to occur after a meal (26.5 %), at work/school
(29.4 %), during times of stress (29.4 %) and during
menstruation (48.0 %, females only). IBS-C subjects were
more likely to report that the bothersome symptoms
usually occur throughout the day or during a non-
specific period of time rather than at a regular time
during the day (data were not shown).
Discussion
We conducted a large-scale Internet survey investigating
30,000 adults from the general public throughout Japan.
In this study, we estimated frequencies of the subtypes of
IBS using the Rome III diagnostic questionnaire [16, 17],
and then investigated what is the most bothersome
symptom and what factors in the daily life exaggerate the
dominant symptoms among subjects with IBS-C. As long
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as we know, this is the first report on a large number
of subjects diagnosed as IBS-C demonstrating that
the degree of anxiety in their daily lives is not always
associated with frequency of bowel movement. Fur-
thermore, we also found that the most bothersome
symptom, abdominal bloating, occurs most often after
meal, subsequently at work or school and during time
of stress in subjects with IBS-C.
The sensation of abdominal bloating may affect 10 to
30 % of healthy subjects and up to 96 % of patients with
IBS [9]. Abdominal bloating is more often noted by
females with IBS than males, with symptoms increasing
in relation to menses [18]. Abdominal bloating is associ-
ated with decreased QOL and may cause a higher num-
ber of physician visits [19]. Indeed, the IBS symptom
severity scale (IBS-SSS) [20], which is widely used to
assess the severity of IBS, consists of the item on the
severity score for abdominal bloating as well as abdom-
inal pain. However, the presence of abdominal bloating
in other functional GI disorders and even in healthy
subjects [19] means that it is not necessarily considered
a diagnostic criterion for IBS.
‘Abdominal bloating’ is not always a specific term that
implies both to the subjective sensation and to the
objective or ‘visible’ abdominal distention [21]. In the
present study, the symptom descriptions in Japanese,
‘abdominal bloating’, ‘abdominal distention’, ‘sensation of
excessive gas’, ‘tightness in the abdomen’ and ‘abdominal
fullness’ were used as independent symptomatic items
on the main questionnaire. In our findings, the most
common symptom of these 5 terms which IBS subjects
expressed during constipation was abdominal bloating
and the fewest was abdominal fullness (see Table 3).
Previous findings of abdominal girth using plethys-
mography [21, 22] may support our results of different
frequencies of abdominal bloating and distention in
subjects with IBS-C. Using this technique it has been
demonstrated that most patients who have abdominal
distention also report abdominal bloating and that pa-
tients with bloating alone have lower sensory thresholds
in the rectum compared to healthy subjects, whereas
those with abdominal bloating and distention have normal
or slightly higher sensory thresholds [21]. On the other
hand, it has been reported that increase in abdominal
girth in a day directly correlated with orocecal and colonic
transit times, and inversely with stool consistency [22].
Therefore, abdominal bloating alone may be more
reflection of visceral hypersensitivity, whereas abdom-
inal bloating with distension may be more of a peripheral
physiological problem.
In our subjects with IBS-C, the degree of anxiety in
their daily lives was associated with severity of abdom-
inal pain, discomfort and bloating, but not with fre-
quency of bowel movement. It has been demonstrated
that IBS patients feel more stress which may exaggerate
IBS symptoms such as abdominal pain compared to
healthy subjects [5]. In patients with IBS, psychological
or physiological stimulus (i.e., stress) alters both vis-
ceral perception (mostly, hypersensitivity) [23–25] and
colonic motility (mostly, hypercontractility even in IBS-C)
Table 2 Comparisons of beliefs about bowel habit between IBS-C and controls (Main study)
Controls (n = 746), n (%) IBS-C (n = 759), n (%) p-value
Female/male number 537/209 (72.0/28.0) 541/218 (71.3/28.7) n.s.
Age (mean ± SD, years) 47 ± 14 47 ± 14 n.s.
Frequency of bowel habit (median, times/week) 7 3 <0.01
Ideal frequency of bowel habit <0.01
6 times/week or less 113 (15.1) 165 (21.7)
7 times/week 581 (77.9) 563 (74.2)
8 times/week or more 52 (7.0) 31 (4.1)
Considered bowel habit to be an indicator of health <0.01
None 291 (39.0) 71 (9.4)
Sometimes 206 (27.6) 221 (29.1)
Often 90 (12.1) 186 (24.5)
Mostly 69 (9.2) 148 (19.5)
Always 90 (12.1) 133 (17.5)
Degree of anxiety in daily life <0.01
None 403 (54.0) 176 (23.2)
Sometimes 283 (37.9) 440 (58.0)
Often 46 (6.2) 111 (14.6)
Almost 14 (1.9) 32 (4.2)
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Table 3 Associations between the degree of anxiety and GI symptoms in subjects with IBS-C
GI symptoms/Degree of anxiety None Sometimes Often Always Kendall’s τ
Abdominal discomfort 0.09**
No (n = 271) 76 153 34 8
Yes (n = 488, 64.3 %) 100 287 77 24
Abdominal pain 0.11**
No (n = 538) 132 323 70 13
Yes (n = 211, 29.1 %) 44 117 41 19
Abdominal bloating 0.08*
No (n = 151) 42 91 13 5
Yes (n = 608, 80.1 %) 134 349 98 27
Abdominal distention 0.11**
No (n = 368) 94 224 39 11
Yes (n = 391, 51.5 %) 82 216 72 21
Sensation of excessive gas 0.11**
No (n = 218) 65 122 25 6
Yes (n = 541, 71.3 %) 111 318 86 26
Tightness in the abdomen 0.11**
No (n = 408) 108 237 52 11
Yes (n = 351, 46.2 %) 68 203 59 21
Abdominal fullness 0.08*
No (n = 636) 157 364 92 23
Yes (n = 123, 16.2 %) 19 76 19 9
Borborygmus 0.06
No (n = 626) 148 367 91 20
Yes (n = 133, 17.5 %) 28 73 20 12
Increase in passing of gas 0.08*
No (n = 369) 99 208 48 14
Yes (n = 390, 51.4 %) 77 232 63 18
Decrease in passing of gas 0.01
No (n = 736) 172 425 109 30
Yes (n = 23, 3.0 %) 4 15 2 2
Incomplete evacuation 0.00
No (n = 326) 72 198 41 15
Yes (n = 433, 57.0 %) 104 242 70 17
Urgency 0.04
No (n = 673) 156 397 95 25
Yes (n = 86, 11.3 %) 20 43 16 7
Sensation of anorectal obstruction/blockage 0.01
No (n = 348) 86 194 54 14
Yes (n = 411, 54.2 %) 90 246 111 18
Frequency of bowel habit in a week −0.04
> 1 time (n = 15) 3 8 3 1
1 time (n = 60) 6 39 12 3
2 times (n = 156) 37 94 19 6
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[26, 27]. However, it has been reported that only 11.5 % of
patients with IBS-C showed delayed colonic transit [11].
In addition, no relationship has been detected between
stress factors and colonic transit in IBS patients [28].
These findings suggest that lower frequency of bowel
movement in IBS-C may not always reflect inhibition of
bowel movement by stress.
IBS patients often relate their symptoms to the intake
of certain foods. IBS symptoms such as abdominal pain
and bloating occur or are exacerbated postprandially in
approximately two-thirds of patients [3, 4]. We have pre-
viously reported that female subjects with IBS had more
irregular meals and skipped meals more frequently com-
pared to non-IBS subjects in nursing and medical school
students [29]. Furthermore, IBS patients showed an
exaggerated sensory component of the gastrocolonic re-
sponse, expressed as lowered colonic perception thresh-
olds and increased viscerosomatic referral area for
abdominal pain after duodenal lipid infusion [30]. On the
other hand, an intestinal transit study using scintigraphy
revealed that IBS-C patients showed normal ileocolonic
transit but somewhat delayed colonic transit in response
to meal ingestion [31]. We have also demonstrated that
meal ingestion did not induce altered colonic motility re-
sponse in patients with IBS-C [27]. Therefore, exaggerated
abdominal boating in IBS-C subjects after the meals in
this study may be due to increased visceral perception,
increased gut contractions and impaired propulsive move-
ment in response to the nutritions.
A limitation of our study was to use the Internet-
based survey. Subjects who were interested in own
health might be more likely to participate in this survey.
In the present study, 30,000 samples were collected from
the large monitor panel throughout Japan and set same
numbers of sex and several aged group flames. There-
fore, we believe ascertainment bias is unlikely because
the prevalence of overall IBS and IBS-C using the Rome
III diagnostic criteria was similar to what has been
reported previously for Japan [32, 33] or the other coun-
tries [34, 35]. Another limitation was that we did not
investigate whether the presence of an organic GI
disease and/or the other comorbid disease. It has been
reported that IBS patients have more somatic/psychiatric
comorbidities which may affect their daily lives compared
to non-IBS subjects [36].
To summarize, a large population-based Internet sur-
vey has shown that a number of similarities between the
Western countries and Japan, including a similar preva-
lence of IBS-C and a similar frequency of abdominal
bloating in subjects with IBS-C. We have also shown
Table 3 Associations between the degree of anxiety and GI symptoms in subjects with IBS-C (Continued)
3 times (n = 152) 40 78 25 9
4 times (n = 85) 22 49 11 3
5 times (n = 79) 17 48 11 3
6 times (n = 52) 12 31 7 2
7 times (n = 111) 26 61 20 4
8 times or more (n = 49) 13 32 3 1
*p < 0.05, **p < 0.01, the Kendall’s τ-b
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Fig. 1 The frequencies of the most bothersome symptom reported by subjects with IBS-C (n = 759)
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important similarities with the previous surveys includ-
ing a similar association of severity of abdominal pain
with the degree of anxiety and a similar association of
occurrence/exaggeration of IBS symptoms with meal in-
gestion and with perceived stress. Thus, these trigger
factors are considered to be generalizable even in IBS-C.
In constant, a significant association of frequency of
bowel movement with the degree of anxiety has failed
to be observed in IBS-C subjects.
Conclusions
Our findings suggest that abdominal bloating has a
great impact on the daily lives of subjects diagnosed with
IBS-C. Not only bowel movement/abdominal pain but
also abdominal bloating should be evaluated in patients
with IBS-C.
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